Technical Analysis for APLS - Apellis Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 19.97 10.64% 1.92
APLS closed up 10.64 percent on Thursday, September 20, 2018, on 1.82 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Flat Up Up
See historical APLS trend table...

Date Alert Name Type % Chg
Sep 20 Crossed Above 20 DMA Bullish 0.00%
Sep 20 Crossed Above 50 DMA Bullish 0.00%
Sep 20 MACD Bullish Centerline Cross Bullish 0.00%
Sep 20 MACD Bullish Signal Line Cross Bullish 0.00%
Sep 20 Pocket Pivot Bullish Swing Setup 0.00%
Sep 20 Multiple of Ten Bearish Other 0.00%
Sep 19 50 DMA Resistance Bearish 10.64%
Sep 19 MACD Bearish Centerline Cross Bearish 10.64%
Sep 19 Spinning Top Other 10.64%
Sep 19 NR7 Range Contraction 10.64%

Older signals for APLS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The Company is developing APL-2 for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) by subcutaneous injection, which is an injection into the tissue under the skin. It is developing APL-2 for the treatment of geographic atrophy (GA) and intermediate age-related macular degeneration (AMD) by intravitreal injection, which is an injection into the eye. The Company is developing APL-1 for the treatment of chronic obstructive pulmonary disease (COPD) by inhaled administration.
Is APLS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.0
52 Week Low 12.45
Average Volume 240,776
200-Day Moving Average 20.0203
50-Day Moving Average 18.2
20-Day Moving Average 18.601
10-Day Moving Average 18.393
Average True Range 1.1812
ADX 17.7
+DI 25.5062
-DI 19.4597
Chandelier Exit (Long, 3 ATRs ) 16.6164
Chandelier Exit (Short, 3 ATRs ) 20.2936
Upper Bollinger Band 20.0729
Lower Bollinger Band 17.1291
Percent B (%b) 0.97
BandWidth 15.826031
MACD Line 0.097
MACD Signal Line 0.0174
MACD Histogram 0.0796
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.63
Resistance 3 (R3) 22.35 21.18 22.18
Resistance 2 (R2) 21.18 20.51 21.32 22.03
Resistance 1 (R1) 20.58 20.09 20.88 20.86 21.89
Pivot Point 19.41 19.41 19.57 19.55 19.41
Support 1 (S1) 18.81 18.74 19.11 19.09 18.05
Support 2 (S2) 17.64 18.32 17.78 17.91
Support 3 (S3) 17.04 17.64 17.76
Support 4 (S4) 17.32